Erratum to "Is minor salivary gland biopsy more than a diagnostic tool in primary Sjorgren's syndrome? Association between clinical, histopathological, and molecular features: A retrospective study" [Semin Arthritis Rheum 44 (2014) 314-324] DOI: 10.1016/j.semarthrit.2014.05.015;Is minor salivary gland biopsy more than a diagnostic tool in primary Sjorgren's syndrome? Association between clinical, histopathological, and molecular features: A retrospective study

Seminars in Arthritis and Rheumatism

Volumn 44, Issue 3, 2014, Pages 314-324

  Carubbi, Francesco ^a   Alunno, Alessia ^b   Cipriani, Paola ^a   Di Benedetto, Paola ^a   Ruscitti, Piero ^a   Berardicurti, Onorina ^a   Bartoloni, Elena ^b   Bistoni, Onelia ^b   Caterbi, Sara ^b   Ciccia, Francesco ^c   Triolo, Giovanni ^c   Gerli, Roberto ^b   Giacomelli, Roberto ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

BAFF; CCL19; CCL21; CCR7; CXCL12; CXCL13; CXCR4; CXCR5; Germinal center; LT ; LT ; Minor salivary glands; Sjorgren's syndrome

Indexed keywords

B CELL ACTIVATING FACTOR; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; EOSIN; HEMATOXYLIN; LYMPHOTOXIN ALPHA BETA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1; BIOLOGICAL MARKER; CYTOKINE;

ADULT; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELL COMPARTMENTALIZATION; CHISHOLM GRADING SYSTEM; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GERMINAL CENTER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; MASON GRADING SYSTEM; MOLECULAR DIAGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SALIVARY GLAND BIOPSY; SALIVARY GLAND SWELLING; SCORING SYSTEM; SJOEGREN SYNDROME; SWELLING; T LYMPHOCYTE; TARPLEY SCORE; BIOPSY; METABOLISM; MIDDLE AGED; MINOR SALIVA GLAND; PATHOLOGY; SJOGREN'S SYNDROME;

ADULT; B-LYMPHOCYTES; BIOLOGICAL MARKERS; BIOPSY; CYTOKINES; FEMALE; GERMINAL CENTER; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SALIVARY GLANDS, MINOR; SJOGREN'S SYNDROME; T-LYMPHOCYTES;

EID: 84908871115     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2015.04.010     Document Type: Erratum

References (61)

1. Mavragani C.P., Nezos A., Moutsopoulos H.M. New advances in the classification, pathogenesis and treatment of Sjogren's syndrome. Curr Opin Rheumatol 2013, 25:623-629.
2. Nocturne G., Mariette X. Advances in understanding the pathogenesis of primary Sjögren's syndrome. Nat Rev Rheumatol 2013, 9:544-556.
3. Quartuccio L., Isola M., Baldini C., Priori R., Bartoloni Bocci E., Carubbi F., et al. Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. J Autoimmun 2013, 10.1016/j.jaut.2013.10.002.
4. Greenspan J.S., Daniels T.E., Talal N., Sylvester R.A. The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol 1974, 37:217-229.
5. Daniels T.E. Labial salivary gland biopsy in Sjögren's syndrome: assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984, 27:147-156.
6. Chisholm D.M., Mason D.K. Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol 1968, 21:656-660.
7. Tarpley T.M., Anderson L.G., White C.L. Minor salivary gland involvement in Sjogren's syndrome. Oral Surg Oral Med Oral Pathol 1974, 37:64-74.
8. Daniels T.E., Whitcher J.P. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren's syndrome. Arthritis Rheum 1994, 37:869-877.
9. Liquidato B.M., SolerRde C., BussolotiFilho I. Evaluation of the concordance of sialometry and salivary glands scintigraphy in dry mouth patients. Braz J Otorhinolaryngol 2006, 72:116-119.
10. Liquidato B.M., Duarte Barros M., Bussoloti Filho I., Pereira C.S.B., Macéa M.I.M. Minor salivary glands morphology in xerostomia patients. Int J Morphol 2006, 24:489-493.
11. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
12. Shiboski S.C., Shiboski C.H., Criswell L., Baer A., Challacombe S., Lanfranchi H., et al. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res 2012, 64:475-487.
13. Guellec D., Cornec D., Jousse-Joulin S., Marhadour T., Marcorelles P., Pers J.O., et al. Diagnostic value of labial minor salivary gland biopsy for Sjögren's syndrome: a systematic review. Autoimmun Rev 2013, 12:416-420.
14. Christodoulou M.I., Kapsogeorgou E.K., Moutsopoulos H.M. Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome. J Autoimmun 2010, 34:400-407.
15. Kapsogeorgou E.K., Christodoulou M.I., Panagiotakos D.B., Paikos S., Tassidou A., Tzioufas A.G., et al. Minor salivary gland inflammatory lesions in Sjogren syndrome: do they evolve?. J Rheumatol 2013, 40:1566-1571.
16. Zhou D., Chen Y.T., Chen F., Gallup M., Vijmasi T., Bahrami A.F., et al. Critical involvement of macrophage infiltration in the development of Sjögren's syndrome-associated dry eye. Am J Pathol 2012, 181:753-760.
17. Aloisi F., Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006, 6:205-217.
18. Bombardieri M., Barone F., Humby F., Kelly S., McGurk M., Morgan P., et al. Activation induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialadenitis and MALT lymphoma in Sjogren's syndrome. J Immunol 2007, 179:4929-4938.
19. Salomonsson S., Jonsson M.V., Skarstein K., Brokstad K.A., Hjelmström P., Wahren-Herlenius M., et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum 2003, 48:3187-3201.
20. Halse A.-K., Marthinussen M.C., Wahren-Herlenius M., Jonsson R. Isotype distribution of anti-Ro/SS-A and anti-La/SS-B antibodies in plasma and saliva of patients with Sjögren's syndrome. Scand J Rheumatol 2000, 29:13-19.
21. Jonsson M.V., Skarstein K., Jonsson R., Brun J.G. Serological implications of germinal center-like structures in primary Sjögren's syndrome. J Rheumatol 2007, 34:2044-2049.
22. Theander E., Vasaitis L., Baecklund E., Nordmark G., Warfvinge G., Liedholm R., et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome. Ann Rheum Dis 2011, 70:1363-1368.
23. Risselada A.P., Looije M.F., Kruize A.A., Bijlsma J.W., van Roon J.A. The role of ectopic germinal centers in the immunopathology of primary Sjögren's syndrome: a systematic review. Semin Arthritis Rheum 2013, 42:368-376.
24. Szodoray P., Alex P., Jonsson M.V., Knowlton N., Dozmorov I., Nakken B., et al. Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF. Clin Immunol 2005, 117:168-176.
25. Reksten T.R., Jonsson M.V., Szyszko E.A., Brun J.G., Jonsson R., Brokstad K.A. Cytokine and autoantibody profiling related to histopathological features in primary Sjogren's syndrome. Rheumatology (Oxford) 2009, 48:1102-1106.
26. Le Pottier L., Devauchelle V., Fautrel A., Daridon C., Saraux A., Youinou P., et al. Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells. J Immunol 2009, 182:3540-3547.
27. Reksten T.R., Johnsen S.J., Jonsson M.V., Omdal R., Brun J.G., Theander E., et al. Genetic associations to germinal centre formation in primary Sjogren's syndrome. Ann Rheum Dis 2013, http://doi:annrheumdis-2012-202500.
28. Youinou P., Pers J.O. Disturbance of cytokine networks in Sjogren's syndrome. Arthritis Res Ther 2011, 13:227.
29. Alunno A., Bistoni O., Bartoloni E., Caterbi S., Bigerna B., Tabarrini A., et al. IL-17-producing CD4-CD8-T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome. Ann Rheum Dis 2013, 72:286-292.
30. Ciccia F., Guggino G., Giardina A., Ferrante A., Carubbi F., Giacomelli R., et al. The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjogren's syndrome. Expert Rev Clin Immunol 2014, 10:533-541.
31. Alunno A., Petrillo M.G., Bistoni O., Bartoloni E., Caterbi S., Bianchini R., et al. Characterization of a new regulatory CD4+ T-cell subset in primary Sjögren's syndrome. Rheumatology (Oxford) 2013, 52:1387-1396.
32. Christodoulou M.I., Kapsogeorgou E.K., Moutsopoulos N.M., Moutsopoulos H.M. Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors. Am J Pathol 2008, 173:1389-1396.
33. Alunno A., Carubbi F., Bistoni O., Caterbi S., Bartoloni E., Bigerna B., et al. CD4-CD8-T-cells in primary Sjögren's syndrome: association with the extent of glandular involvement. J Autoimmun 2014, 10.1016/j.jaut.2014.01.030.
34. Cornec D., Devauchelle-Pensec V., Tobón G.J., Pers J.O., Jousse-Joulin S., Saraux A. B cells in Sjögren's syndrome: from pathophysiology to diagnosis and treatment. J Autoimmun 2012, 39:161-167.
35. Routsias J.G., Goules J.D., Charalampakis G., Tzima S., Papageorgiou A., Voulgarelis M. Malignant lymphoma in primary Sjögren's syndrome: an update on the pathogenesis and treatment. Semin Arthritis Rheum 2013, 43:178-186.
36. Moisini I., Davidson A. BAFF: a local and systemic target in autoimmune diseases. Clin Exp Immunol 2009, 158:155-163.
37. Thien M., Phan T.G., Gardam S., Amesbury M., Basten A., Mackay F., et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 2004, 20:785-798.
38. Groom J., Kalled S.L., Cutler A.H., Olson C., Woodcock S.A., Schneider P., et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J Clin Invest 2002, 109:59-68.
39. Lavie F., Miceli-Richard C., Quillard J., Roux S., Leclerc P., Mariette X. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjogren's syndrome. J Pathol 2004, 202:496-502.
40. Pers J.O., Daridon C., Devauchelle V., Jousse S., Saraux A., Jamin C., et al. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci 2005, 1050:34-39.
41. Mariette X., Roux S., Zhang J., Bengoufa D., Lavie F., Zhou T., et al. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann Rheum Dis 2003, 62:168-171.
42. Corsiero E., Bombardieri M., Manzo A., Bugatti S., Uguccioni M., Pitzalis C. Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases. Immunol Lett 2012, 145:62-67.
43. Van de Pavert S.A., Mebius R.E. New insights into the development of lymphoid tissues. Nat Rev Immunol 2010, 10:664-674.
44. Barone F., Bombardieri M., Manzo A., Blades M.C., Morgan P.R., Challacombe S.J., et al. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren's syndrome. Arthritis Rheum 2005, 52:1773-1784.
45. Amft N., Curnow S.J., Scheel-Toellner D., Devadas A., Oates J., Crocker J., et al. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjogren's syndrome. Arthritis Rheum 2001, 44:2633-2641.
46. Xanthou G., Polihronis M., Tzioufas A.G., Paikos S., Sideras P., Moutsopoulos H.M. 'Lymphoid' chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients. Possible participation in lymphoid structure formation. Arthritis Rheum 2001, 44:408-418.
47. Salomonsson S., Larsson P., Tengnér P., Mellquist E., Hjelmström P., Wahren-Herlenius M. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome. Scand J Immunol 2002, 55:336-342.
48. Barone F., Bombardieri M., Rosado M.M., Morgan P.R., Challacombe S.J., De Vita S., et al. CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization. J Immunol 2008, 180:5130-5140.
49. Hansen A., Reiter K., Ziprian T., Jacobi A., Hoffmann A., Gosemann M., et al. Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome. Arthritis Rheum 2005, 52:2109-2119.
50. Hansen A., Lipsky P.E., Dörner T. B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther 2007, 9:218.
51. Bombardieri M., Barone F., Lucchesi D., Nayar S., van den Berg W.B., Proctor G., et al. Inducible tertiary lymphoid structures, autoimmunity, and exocrine dysfunction in a novel model of salivary gland inflammation in C57BL/6 mice. J Immunol 2012, 189:3767-3776.
52. Link A., Vogt T.K., Favre S., Britschgi M.R., Acha-Orbea H., Hinz B., et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol 2007, 8:1255-1265.
53. Ishimaru N., Yamada A., Nitta T., Arakaki R., Lipp M., Takahama Y., et al. CCR7 with S1P1 signaling through AP-1 for migration of Foxp3+ regulatory T-cells controls autoimmune exocrinopathy. Am J Pathol 2012, 180:199-208.
54. Pereira J.P., Kelly L.M., Cyster J.G. Finding the right niche: B-cell migration in the early phases of T-dependent antibody responses. Int Immunol 2010, 22:413-419.
55. Varela-Centelles P., Sanchez-Sanchez M., Seoane J. Lip biopsy for the diagnosis of Sjögren's syndrome: beware of the punch. Int J Oral Maxillofac Surg 2013, 10.1016/j.ijom.2013.05.014.
56. Gerli R., Muscat C., Giansanti M., Danieli M.G., Sciuto M., Gabrielli A., et al. Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder. Br J Rheumatol 1997, 36:969-975.
57. Vinuesa C.G., Sanz I., Cook M.C. Dysregulation of germinal centres in autoimmune disease. Nat Rev Immunol 2009, 9:845-857.
58. Daniels T.E., Cox D., Shiboski C.H., Schiødt M., Wu A., Lanfranchi H., et al. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants. Arthritis Rheum 2011, 63:2021-2030.
59. Voulgarelis M., Tzioufas A.G. Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome. Nat Rev Rheumatol 2010, 6:529-537.
60. Bahler D.W., Miklos J.A., Swerdlow S.H. Ongoing Ig gene hypermutationin salivary gland mucosa-associated lymphoid tissue type lymphomas. Blood 1997, 89:3335-3344.
61. Carubbi F., Cipriani P., Marrelli A., Benedetto P., Ruscitti P., Berardicurti O., et al. Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. Arthritis Res Ther 2013, 15:R172. 10.1186/ar4359.